{
    "Trade/Device Name(s)": [
        "BaseSens I Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Hygieia, Inc.",
    "510(k) Number": "K093475",
    "Predicate Device Reference 510(k) Number(s)": [
        "K080923",
        "K083468"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "January 17, 2010",
    "Summary Letter Received Date": "January 19, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BaseSens I Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric method",
        "Glucose oxidase chemical reaction"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for BaseSens I Blood Glucose Monitoring System, a rebranded version of CareSens N for quantitative glucose measurement using amperometric method.",
    "Indications for Use Summary": "Used for quantitative measurement of glucose levels in capillary whole blood as an aid in monitoring diabetes management at home or in clinical settings; for in vitro diagnostic use only, not intended for diagnosis or screening of diabetes, nor for neonates, with alternate site testing during steady-state blood glucose conditions.",
    "fda_folder": "Clinical Chemistry"
}